Social & Media
CLINUVEL take pride in connecting with as many people as possible online. Come join us in any of our channels listed below to keep up to date for latest company developments:
|CLINUVEL||The Photoprotection Network||The Photoprotection Channel|
CLINUVEL takes pride in connecting with as many people as possible online. Join us on any of our social channels to keep up to date for latest company developments.
This is a regular series about the big issues that affect CLINUVEL and the broader biopharmaceutical sector, The column is written by Giles Delaney, an experienced business journalist who has worked for newspapers and magazines in the Asia Pacific for more than three decades. As a guest writer, Delaney retains full editorial freedom and his views are his own.
Philippe Wolgen of CLINUVEL PHARMACEUTICALS driven by competition
New Treatment Inspires Hope for the Battle Against Sun Allergy
Drug Offers Hope Against Disease Where Sunlight Causes Pain
Implanted drug improves tolerance of sunlight in rare condition
CLINUVEL welcomes the opportunity to hear from our stakeholders on social media, and our channels have been designed to provide news updates and share relevant information.